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Science Doctoral Program, University of Florida, Gainesville, FL, United States, 3 Department of Mechanical and Aerospace 
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Walking after stroke is often described as requiring excessive muscle co-contraction, 
yet, evidence that co-contraction is a ubiquitous motor control strategy for this pop-
ulation remains inconclusive. Co-contraction, the simultaneous activation of agonist 
and antagonist muscles, can be assessed with electromyography (EMG) but is often 
described qualitatively. Here, our goal is to determine if co-contraction is associated 
with gait impairments following stroke. Fifteen individuals with chronic stroke and nine 
healthy controls walked on an instrumented treadmill at self-selected speed. Surface 
EMGs were collected from the medial gastrocnemius (MG), soleus (SOL), and tibialis 
anterior (TA) of each leg. EMG envelope amplitudes were assessed in three ways: 
(1) no normalization, (2) normalization to the maximum value across the gait cycle, or 
(3) normalization to maximal M-wave. Three co-contraction indices were calculated 
across each agonist/antagonist muscle pair (MG/TA and SOL/TA) to assess the effect 
of using various metrics to quantify co-contraction. Two factor ANOVAs were used to 
compare effects of group and normalization for each metric. Co-contraction during the 
terminal stance (TSt) phase of gait is not different between healthy controls and the 
paretic leg of individuals post-stroke, regardless of the metric used to quantify co-con-
traction. Interestingly, co-contraction was similar between M-max and non-normalized 
EMG; however, normalization does not impact the ability to resolve group differences. 
While a modest correlation is revealed between the amount of TSt co-contraction and 
walking speed, the relationship is not sufficiently strong to motivate further exploration of 
a causal link between co-contraction and walking function after stroke. Co-contraction 
does not appear to be a common strategy employed by individuals after stroke. We 
recommend exploration of alternative EMG analysis approaches in an effort to learn 
more about the causal mechanisms of gait impairment following stroke.
Keywords: stroke, co-contraction, electromyography, walking, methodology, motor disorders
inTrODUcTiOn
After a stroke, most individuals experience lifelong walking impairments, including forward propul-
sion deficits, which contribute to metabolically inefficient gait (1–4). Abnormal muscle activation 
patterns, especially excessive co-contraction, are commonly argued to be a major contributing factor 
to these walking impairments (5–7). Co-contraction refers to simultaneous activity in agonist and 
TaBle 1 | Demographics.
control stroke
Demographics
n 9 15
Sex (m/f) 5/4 14/1
Age (years) 60 ± 9.33 65.87 ± 9.76
Self-selected walking speed (m/s) 1.40 ± 0.2a 0.93 ± 0.3a
Chronicity (years) 5.52 ± 3.73
Affected side (r/l) 8/7
clinical characteristics
Routine ankle foot orthosis (AFO) use (n) 4
LE Fugl-Meyer Motor Score (/34) 30 (16, 34)
Dynamic Gait Index (/24) 21 (10, 24)
Short Physical Performance Battery (/12) 11 (7, 12)
Demographic and clinical data are presented mean ± SD and median (range), 
respectively. Of the four individuals who routinely use an ankle-foot orthosis, three 
typically use a custom-molded AFO and one uses a prefabricated Aircast®.
aIndicates a significant difference between groups, p < 0.05.
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antagonist muscles across the same joint (6, 8). This phenomenon 
is sometimes called agonist/antagonist co-activation or simply 
co-activation. However, co-activation can also refer to simulta-
neous activity in synergist muscles. Here, we will use the term 
co-contraction and address the relationship between agonist and 
antagonist muscle co-activity.
Co-contraction is a normal motor control strategy observed 
in healthy individuals during functional motor tasks. Its pres-
ence varies in response to environmental and task demands on 
different time scales. For example, when encountering uncer-
tainty, such as challenges to posture and balance, increased 
co-contraction can be observed as an early response to the 
novel environment (9). Evidence suggests that co-contraction 
facilitates rapid torque development (10), compensates for 
non-linearities in muscle properties and torque scaling (11), 
and counteracts agonist torques and off-axis torques (12, 13). 
Thus, co-contraction affords a robust mechanism to rapidly 
counteract perturbations. Co-contraction is also often present 
when motor tasks are novel or require limb stabilization for 
performance accuracy. Over a longer time scale (e.g., minutes, 
hours or days), co-contraction decreases progressively. Indeed, 
an asymptote in co-contraction often serves as a hallmark of 
motor learning and adaptation (14, 15). Important to its role 
as a normal motor control strategy, co-contraction is actively 
modulated during movements such as walking, occurring more 
prominently at predictable points in the gait cycle to stabilize 
joints and enable efficient walking (8).
In contrast to this normal pattern of co-contraction, chronic 
presence of excessive or invariant co-contraction should reflect 
pathology (16). Disturbed voluntary muscle activation follow-
ing stroke is thought to involve excessive co-contraction, which 
may stem from diffuse descending motor drive or exaggerated 
stretch reflexes generated in the antagonist muscle by movement 
(i.e., antagonist restraint) (17, 18). Clinical perspectives have 
emphasized the presence of excessive and invariant co-contrac-
tion in neuropathologic conditions, fueling an expectation that 
it is ubiquitously present (16, 19–21). However, the literature to 
date remains inconclusive regarding either its presence or causal 
role in motor dysfunction (10, 19–21). Furthermore, it is thought 
that co-contraction contributes to slow, inefficient walking after 
stroke (5, 6, 22, 23). Importantly, if excessive co-contraction is 
present during walking after stroke, it should be quantifiable and 
associated with robust measures of gait impairment, particularly, 
generation of plantarflexor power.
While objective, quantifiable methods exist for analyzing 
co-contraction in healthy individuals, the literature provides 
no “best” method to account for co-contraction as a feature of 
pathologic muscle activation patterns (24). We surveyed the 
existent literature and selected two popular metrics. The first, 
developed by Falconer and Winter, is a metric based on normal 
gait patterns from ten healthy adults (8). This method computes 
a ratio of antagonist to agonist electromyography (EMG) activity 
within each phase of the gait cycle. Another common method 
quantifies the “wasted contraction” (WC) shared between an 
agonist and antagonist muscle by denoting the smaller of the two 
traces as the WC and the remaining EMG activity as the “effec-
tive contraction,” which generates movement. This approach was 
developed by researchers studying upper limb motor adaptation 
and computational motor control (25). To our knowledge, the 
WC measure has not been applied to evaluate co-contraction 
during walking. Both metrics evaluate muscle activation patterns 
in a manner that does not account for the biomechanical role of 
each muscle within the task. That is, the larger magnitude EMG 
signal is assumed to arise from the agonist and the smaller signal 
from the antagonist. However, this assumption does not always 
hold, especially after stroke. Impaired EMG amplitude and phas-
ing following stroke may, therefore, require a metric that is sensi-
tive to these changes in muscle roles throughout the gait cycle. 
EMG normalization also varies considerably when quantifying 
co-contraction, which may further influence data interpretation 
and outcomes.
The goal of the present study is to assess the relationship 
between ankle co-contraction and gait impairment following 
stroke. Given the challenges involved with detecting co-
contraction in a pathologic population, we will investigate the 
effect of various methods for quantifying co-contraction. Here, 
we introduce a modified version of the Falconer and Winter 
metric in which the agonist and antagonist muscle roles are 
prescribed within each phase of the gait cycle. We will investigate 
the effects of co-contraction metric and EMG normalization in 
order to comprehensively assess the presence and magnitude of 
pathologic co-contraction. Our results will allow us to determine 
whether, and how, the metric impacts the ability to detect patho-
logic co-contraction patterns after stroke, while accounting for 
inconsistencies in the literature that may underlie detection of 
this phenomenon.
MaTerials anD MeThODs
subjects
This is a subgroup analysis from a larger study. We included 15 
individuals post-stroke and 9 healthy controls. Demographic data 
are presented in Table  1. Overall, participants were included if 
they were: greater than 18 years of age, able to walk independently 
for a distance of at least 15 m with or without an assistive device, 
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and medically stable. Participants post-stroke were included 
following clinical presentation of a single, unilateral stroke— 
confirmed by neuroimaging—at least 6 months prior to enrollment. 
Individuals with brainstem or cerebellar involvement, bilateral 
involvement, major neurologic or neurodegenerative conditions 
other than stroke, orthopedic or cardiovascular conditions that 
precluded walking on a treadmill, or pregnancy were excluded.
Testing occurred at the Brain Rehabilitation Research Center 
in the Malcom Randall VA Medical Center in Gainesville, FL, 
USA.
instrumentation and Protocol
Participants walked on an instrumented split-belt treadmill 
(Bertec, Columbus, OH, USA, sampling frequency 2,000  Hz) 
at their self-selected speed. No handrail support was provided 
and participants wore a modified mountain climbing harness 
for fall arrest (Robertson Harness, Henderson, NV, USA); no 
substantial body weight support was provided. Four participants 
regularly used a custom-molded ankle foot orthosis (n = 3) or 
ankle brace (n = 1) on the paretic leg. Two of these participants 
wore an Aircast® AirSport™ (DJO Global, Vista, CA, USA) for 
mediolateral support during testing, while all other participants 
were tested without ankle support. Reflective markers were placed 
over anatomical landmarks using a modified Helen Hayes marker 
set (26). Coordinates of the anterior superior iliac spines were 
located using a digitizing pointer (C-Motion, Inc., Germantown, 
MD, USA). Locations of the medial and lateral malleoli were digi-
tized for AirCast® wearers due to interference with skin contact. 
Marker data were recorded by 12 infrared cameras (Vicon MX, 
Vicon Motion Systems Ltd., Oxford, UK) at 200 Hz.
Surface EMG was recorded using active preamplifiers (MA-
420, Motion Lab Systems, Baton Rouge, LA, USA; input imped-
ance >100,000,000 Ω, CMRR >100 dB at 65 Hz, noise <1.2 μV 
RMS, signal bandwidth 10–2,000  Hz) attached to gel surface 
electrodes (Cleartrace 2, Conmed, Utica, NY, USA). Skin was 
abraded and cleaned with alcohol, then electrodes were placed 
on the muscle belly of the medial gastrocnemius (MG), soleus 
(SOL), and tibialis anterior (TA) of each leg according to the 
SENIAM guidelines (27). To assure maximal resolution, amplifier 
gains were adjusted minimally by visual inspection during iso-
lated ankle movements prior to data collection. EMG data were 
recorded in Signal (Version 6.0, Cambridge Electronic Design, 
Cambridge, England) at 2,000 Hz.
Maximal M-waves (M-max) were elicited through stimulation 
with a Digitimer stimulator (DS-7A or DS-7AH for high-current 
stimulation, Hertfordshire, UK) using either a hand-held bipolar 
stimulator probe (CareFusion, Middleton, WI, USA) or a custom 
monopolar ball electrode. M-max was elicited in the paretic 
or test leg MG/SOL or TA by supramaximal stimulation of the 
tibial nerve or common peroneal nerve, respectively (28). M-max 
amplitudes were averaged across 4–7 consecutive stimulations. 
One control subject was excluded from M-max analysis because 
data were overwritten.
Participants were instructed to walk with their arms relaxed 
at their sides. Data were collected in 1-min walking blocks, with 
seated or standing rest breaks taken as needed.
Data analysis
EMG Processing
EMG data were band-pass filtered to remove noise (fourth 
order Butterworth, cutoff frequency 10–450  Hz), rectified, 
low-pass filtered (fourth order Butterworth), time-normalized 
to a 1,001-point gait cycle, and signal averaged (60 cycles), to 
establish a linear envelope. The ideal low-pass filter frequency 
was determined by each individual’s mean stride time (cutoff 
frequency 5/stride time Hz; control 4.6  ±  0.3  Hz, stroke 
3.9  ±  0.5  Hz), as recommended by Shiavi et  al. (29). The 
linear envelopes were then amplitude-normalized in each of 
three ways: (1) no normalization (non), (2) to the maximum 
value across the gait cycle (max), or (3) to M-max. Data were 
processed using custom MATLAB scripts (The MathWorks 
r2015a, Natick, MA, USA).
Quantification of Co-Contraction
The gait cycle was divided into seven bins using gait events 
extracted from ground reaction force and heel marker data. 
The events defined bins following the standard established by 
the Rancho Los Amigos Medical Center Pathokinesiology Lab: 
loading response (LR), mid-stance (MSt), terminal stance (TSt), 
pre-swing (PSw), initial swing (ISw), mid-swing (MSw), and 
terminal swing (TSw) (30). The three swing bins each represent 
one-third of the swing phase.
We used three metrics to quantify co-contraction. The first 
metric, which we will denote as CItraditional, was first described by 
Falconer and Winter (8). This metric represents a ratio of agonist/
antagonist overlap to total muscle activation. The total antagonist 
activity within each bin, Iant, is calculated as the area under the 
curve created by the smaller EMG envelope as indicated by 
the shaded region in the top row of plots in Figure 1. The total 
activity, Itot, is the sum of the agonist and antagonist EMG areas 
within a given pair of muscles (i.e., MG/TA or SOL/TA). The co-
contraction index can then be quantified as:
 
C traditional ant
tot
I I
I
=
2 100∗ .
 
(1)
A CI value of 100% represents total co-contraction, while 
a value of 0% represents pure agonist activation. This measure 
has been widely cited and applied in the literature (31–35). We 
calculated two co-contraction indices for each phase of the gait 
cycle, one with the MG/TA pairing, and one with the SOL/TA 
pairing.
The second metric, CIfixed, is analogous to the traditional 
Falconer and Winter metric, except the agonist/antagonist 
muscle relationship was fixed to the biomechanical function of 
these muscles within each of the seven bins of the gait cycle, as 
demonstrated by typical EMG patterns of healthy individuals 
(Figure  1, middle plots). During LR, ISw, MSw, and TSw, the 
TA should be the agonist muscle, while the MG should be the 
antagonist:
 
C fixed MG
tot
I I
I
=
2 100∗ .
 
(2)
FigUre 1 | Example co-contraction metrics. (a) Eight gait events dividing the gait cycle into seven phases: loading response (LR), mid-stance (MSt), terminal 
stance (TSt), pre-swing (PSw), initial swing (ISw), mid-swing (MSw), and terminal swing (TSw). Illustrated immediately below, is example EMG in the medial 
gastrocnemius (MG, solid) and tibialis anterior (TA, dotted) for a healthy control (left) and an individual post-stroke (right). The shaded area reflects the area under the 
lower trace at any point, used as the antagonist in the traditional co-contraction index calculations. (B) Illustration using the same example EMG as above, however 
the shaded area reflects the area under the muscle that should be the antagonist within each phase. PSw is not shaded because the antagonist muscle typically 
switches between MG and TA in this phase. (c) The resulting wasted contraction for the same subjects, the lower of the two traces (wide dashes), and the effective 
contraction, which is calculated as the higher trace minus the lower trace (narrow dashes). The wasted contraction index is the mean of the wasted contraction, 
expressed as a percentage of the maximum effective contraction.
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During MSt and TSt, the MG should be the agonist and the TA 
the antagonist muscle:
 
C fixed TA
tot
I I
I
=
2 100∗ .
 
(3)
In health, the ankle muscles switch agonist/antagonist roles 
in PSw; thus, we were unable to calculate a co-contraction index 
during PSw using this method. CIfixed for the SOL/TA pairing was 
calculated in the same manner as Eqs 2 and 3 above; however, 
the SOL was used as the antagonist muscle during LR and the 
swing phases.
The final metric, illustrated in the bottom plots of Figure 1, 
was developed by Thoroughman and Shadmehr to represent the 
amount of “wasted contraction” that occurs due to co-contraction 
(25). Similar to CItraditional, the smaller of the two EMG envelopes 
is designated to represent the contraction that is wasted by 
simultaneous activity in opposing muscles. This amount can be 
subtracted from the EMG envelope of the larger signal to deter-
mine “effective contraction,” or the amount of agonist activation 
that effectively performed the movement. The wasted and effective 
contraction traces can be divided by the maximum effective con-
traction, resulting in units expressed as the percentage of maxi-
mum effective contraction. This step was necessary to compare 
the effects of EMG normalization since the units of wasted and 
effective contractions are the same as the units of the EMG traces 
from which they are based (e.g., microvolts). The mean wasted and 
effective contractions were calculated for each gait phase.
Quantification of Motor Impairment
Clinical and Functional Assessments
We used two functional assessments of motor impairment: the 
lower extremity Fugl-Meyer Assessment of Motor Performance 
FigUre 2 | Reduced concentric ankle plantarflexor power is noted following 
stroke. Example ankle power curves, derived from inverse dynamics, for a 
healthy control (gray) and an individual following stroke (black) demonstrate 
diminished peak concentric plantarflexor power (A2) late in the stance phase 
of gait.
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(LE FMA) and walking speeds (36). Self-selected and fastest 
 comfortable walking speeds (SSWS and FCWS, respectively) were 
captured using 3–5 passes on a 16-foot GaitRite pressure-sensitive 
walkway (Platinum Plus System, Version 3.9, Havertown, PA, 
USA). SSWS involved walking at a casual, comfortable pace. 
Fastest comfortable speed was assessed as the fastest speed 
the participant could safely attain when walking, “as if you are 
crossing the street and the walk signal changed to a red hand.” 
All clinical and functional assessments were performed by a 
licensed physical therapist (VLL).
Ankle Power
We used ankle power to quantify a key biomechanical aspect of 
walking function. Power was calculated using inverse dynamics 
by the following formula:
 P M= ⋅ω,  (4)
where P is the rate of work done by the ankle muscles (i.e., power), 
M is the joint moment, and ω is the angular velocity (37, 38). 
An example ankle power curve is shown in Figure 2. The second 
peak of the ankle power curve, or A2, is prominent in late stance 
for both normal and pathologic gait (37, 39). A2 is often dimin-
ished with aging and in individuals post-stroke (39, 40). Although 
A2 scales with walking speed, the deficit in these individuals is 
present even when compared to speed-matched controls (41, 42). 
Because the plantarflexors are the primary mediators of A2 and 
A2 and accounts for both joint motion and muscular output 
through torque generation (43), this outcome is highly sensitive 
and relevant to functional changes after stroke.
statistics
Data were tested for normality using a Shapiro–Wilk W test. 
In the cases where the assumption of normality was not met 
(all cases except SOL/TA CItraditional), data were transformed using 
a base 10 logarithmic transformation. In the final case, raw data 
were analyzed. Separate two-factor ANOVAs assessed the effects 
of group (control or stroke) and normalization (maximum value, 
M-max, or no normalization) on each of the three co-contraction 
indices and muscle pairs (MG/TA, SOL/TA). Tukey’s Honestly 
Significant Difference was performed post hoc when significant 
effects were detected. To account for multiple comparisons, 
significance was established using a Bonferroni corrected value 
of p < 0.0083. Spearman’s correlations assessed the relationship 
between co-contraction and walking function. The Bonferroni 
corrected significance level for correlation analyses was 
p < 0.0125. Statistical testing was performed in JMP Pro 11 (SAS 
Institute, Inc., Cary, NC, USA).
resUlTs
Visual assessment of EMG patterns during walking revealed 
consistent patterns in healthy controls, accompanied by vast 
heterogeneity in the stroke group. Differences between healthy 
and stroke subjects are most relevant in TSt, where peak plan-
tarflexor EMG tends to occur. TSt is also the gait phase when 
plantarflexor EMG contributes to A2—the most robust measure 
of gait function employed in this study. Moving forward, all 
results will be presented during TSt unless specified otherwise. 
Group co-contraction responses during TSt can be visualized by 
metric in Figure 3 for the paretic leg and Figure 4 for the non-
paretic leg. Because the core findings are largely similar between 
legs and we are primarily interested in paretic leg function, we 
performed statistics only on the paretic leg.
The metric adjusted for the muscles’ biomechanical roles, 
CIfixed, showed no significant main effect of Group or Group ×   
Normalization interaction. In the SOL/TA muscle pairing, there 
was a significant main effect of normalization method (p = 0.0032, 
Figure 3). Post hoc testing revealed that M-max normalization 
produced greater CIfixed than maximum value normalization 
(p = 0.0024). The MG/TA pairing revealed no significant main 
effects.
CItraditional resulted in values similar to CIfixed during TSt, 
and the statistical findings are largely the same. Both muscle 
pairings revealed no significant main effects of Group or 
Group  ×  Normalization interactions. The SOL/TA pairing 
revealed a significant main effect of Normalization (p = 0.0051). 
Post hoc testing revealed that M-max normalization was again 
greater than maximum value normalization (p =  0.0035). The 
MG/TA pairing revealed no significant main effects.
The WC, when expressed as a percentage of the effective con-
traction, has the potential to create outliers when the two EMG 
traces are similar in magnitude. In the case of maximum value 
normalization, one subject’s EMG produced an extreme value for 
both the MG/TA and SOL/TA muscle pairings, corresponding to 
z-scores of 6.3 and 7.0, respectively. Since no data transformation 
could normalize the dataset with outliers of that magnitude, we 
adjusted each of the outliers to a z-score of 3. This step allowed 
for adequate statistical comparison within the remaining dataset. 
Both the MG/TA and SOL/TA muscle pairings revealed only a sig-
nificant main effect of Normalization (p = 0.0008 and p = 0.0005, 
respectively). Post hoc testing for the MG/TA pairing revealed that 
maximum value normalization produced greater WC values than 
both M-max (p = 0.0044) and WC derived from non-normalized 
EMG (p = 0.0018). In the SOL/TA muscle pairing, WC was greater 
with maximum value normalization than M-max normalization 
(p =  0.0004). Because the adjusted outlier would have created 
FigUre 4 | Non-paretic leg co-contraction appears unchanged across group, metric, and normalization method. Plots moving left to right represent three different 
co-contraction indices: a co-contraction ratio with fixed muscle roles derived from referencing healthy EMG (CIfixed, left), a traditional index for co-contraction during 
normal walking (CItraditional, center), and an index of the “wasted contraction” produced by antagonist activation countering agonist activation (right). Co-contraction in 
terminal stance appears unchanged between control (gray) and stroke (black) in both (a) the medial gastrocnemius and tibialis anterior (MG/TA) and (B) the soleus 
and tibialis anterior (SOL/TA).
FigUre 3 | Paretic leg co-contraction following stroke is not different from healthy controls. (a) Co-contraction of the medial gastrocnemius and tibialis anterior 
(MG/TA) in terminal stance is shown by three EMG normalization methods: maximum value (Max), maximal M-wave (M-max), and non-normalized (Non). Plots 
moving left to right represent three different co-contraction indices: a co-contraction ratio with fixed muscle roles derived from referencing healthy EMG (CIfixed, left), a 
traditional index for co-contraction during normal walking (CItraditional, center), and an index of the “wasted contraction” produced by antagonist activation countering 
agonist activation (right). There are no group differences between stroke (gray) and control (black) in any of the three comparisons. (B) Co-contraction of the soleus 
and tibialis anterior (SOL/TA) in terminal stance. Again, there were no significant differences between control and stroke. *Indicates significance with a Bonferroni-
corrected p < 0.0083.
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an even higher mean value for maximum value-normalized WC, 
these significant findings are consistent with the original direc-
tion of the adjusted outlier. When calculating WC, we observed 
an interesting phenomenon. Two subjects with visually different 
EMG patterns revealed comparable WC values in TSt (Figure 5). 
Aside from the maximum value normalization condition, the WC 
FigUre 5 | Two subjects show vastly different EMG with same wasted contraction (WC) value in terminal stance. The left column depicts example EMG for the 
medial gastrocnemius (MG) and tibialis anterior (TA) muscles in (a) a healthy control and (B). an individual post-stroke. The right column depicts the resultant wasted 
and effective contraction, with WC in TSt denoted above each plot.
7
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values tended to have low variability, despite obvious visual dif-
ferences present in the original EMG. This circumstance creates 
a problem for interpreting the WC results, which we will revisit 
in the Section in the discussion.
Non-normalized CIfixed values are moderately correlated with 
functional metrics across groups. We observed similar results 
across all co-contraction indices. Because non-normalized data 
are most straightforward to interpret, we chose this metric to 
perform correlations with functional measures. Therefore, CIfixed 
serves as representative of the patterns present across metrics. 
Four comparisons were made between CIfixed and LE FMA, SSWS, 
FCWS, and A2 (Figure 6). CIfixed was not significantly correlated 
with either LE FMA (Spearman’s ρ = −0.6079, p = 0.0162) or A2, 
our most sensitive assessment of walking function (ρ = −0.4557, 
p = 0.0252). CIfixed was significantly correlated with both SSWS 
(ρ = −0.6438, p = 0.0007) and FCWS (ρ = −0.6026, p = 0.0018).
DiscUssiOn
Despite our systematic analysis of co-contraction during gait, we 
are unable to conclude that co-contraction is ubiquitously present 
post-stroke. As illustrated in Figure 7, this sample of individuals 
post-stroke revealed vast heterogeneity in EMG patterns, and no 
distinct pattern of co-contraction emerged. Furthermore, regard-
less of the metric used to assess co-contraction, our results fail 
to indicate clear differences between stroke and healthy controls. 
Although results reported here are limited to the TSt phase of 
gait, this finding is consistent across all gait phases. Nearly four 
decades of literature discuss pathological co-contraction after 
stroke, arguing for its presence as either study motivation or data 
interpretation, yet failing to show convincing evidence through 
results. Taken together with results of the current analysis, this 
lack of evidence leads us to reconsider the assumption that 
pathological co-contraction is a primary factor contributing to 
impaired gait post-stroke. The following discussion enumerates 
the details leading to this conclusion.
Early studies assessing EMG during gait post-stroke carefully 
described the authors’ observations while presenting mostly 
qualitative evaluations and proposing future avenues of research. 
Knutsson and Richards are often credited for the suggestion that 
co-contraction could be a strategy employed in post-stroke gait, 
but they carefully acknowledged that the heterogeneity present 
within their sample limited their ability to draw distinct conclu-
sions (22). Another group classified whole-leg muscle activation 
patterns, classifying less than half of their sample in the chronic 
phase of recovery as expressing excessive co-contraction (5). 
There is heterogeneity in virtually all motor outcomes measured 
following stroke, and that heterogeneity impacts the ability 
to assess treatment efficacy (44). Equally important, no strong 
evidence has emerged in favor of co-contraction as either 
the predominant strategy or one of a few common strategies 
employed by these individuals. Moreover, the evidence provides 
no indication that mitigating co-contraction is a productive treat-
ment target. Working under the assumption that co-contraction 
indices provide useful information, therefore, limits our ability to 
appropriately quantify motor impairment within this population.
Heterogeneity of responses among individuals post-stroke 
leads many groups to seek a single metric, or a simple collection 
of metrics, which can parse these individual differences. Here, we 
employed a two-factor approach by combining EMG metrics with 
measures of motor or gait impairment. Although our data reveal 
some significant correlations, these are not sufficiently strong to 
support an argument for a causal link between co-contraction 
and impaired biomechanical function. Lower extremity coordi-
nation during gait requires much more than the ankle muscles; 
however, the vital importance of the ankle plantarflexors affords 
an ideal test-bed for assessing the relevance of lower extremity 
co-contraction post-stroke. Yet, no clear patterns emerged. It 
is worth noting that four of the individuals within this sample 
FigUre 7 | Heterogeneity in electromyography (EMG) activation is present following stroke. Healthy control (left) and stroke (right) EMG envelopes are illustrated for 
the: (a) tibialis anterior (TA) and (B) medial gastrocnemius (MG). The heavy line depicts the ensemble average for each group and the cloud illustrates the SEM with 
individual subject responses overlaid (thin lines). Considerable variation in activation patterns of each muscle is apparent within the stroke group, illustrating the 
difficulty inherent in selecting a single metric to capture all of the possible deviations from the pattern of healthy controls.
FigUre 6 | Co-contraction index in terminal stance correlates to some, but not all, indices of motor function. Medial gastrocnemius/tibialis anterior CI_fixed in 
terminal stance with non-normalized EMG varies as a function of: (a) lower extremity Fugl-Meyer (LE FMA), (B) self-selected walking speed (SSWS), (c) fastest 
comfortable walking speed (FCWS), and (D) peak concentric ankle plantarflexor power (A2) for healthy controls (gray), individuals post-stroke (black). The only 
correlations reaching statistical significance occur with SSWS and FCWS.
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regularly wore some form of ankle brace. The extent to which 
bracing impacted the EMG patterns differentially from the stroke 
itself is not known. We compared these participants against those 
who did not wear a brace and found no apparent differences. 
We acknowledge this is a limitation within our sample that may 
be worth exploring in the future. It is also important to note that 
EMG assesses the final common pathway (45), and these periph-
eral signals cannot be used to draw specific conclusions about 
central nervous system function. Although we expect surface 
EMG signals to provide information about motor coordination, 
co-contraction may not be sufficiently robust to explain central 
nervous system dysfunction.
Changing the co-contraction metric offered variable results. 
Contrary to our initial expectations, fixing the biomechani-
cal roles of the muscles was only marginally more informative 
than the existing CI, which was not designed to account for 
abnormal muscle activation patterns. Importantly, the group-
level results were the same; neither metric revealed differences 
between healthy individuals and individuals post-stroke. On the 
group level, even the WC metric performed similarly to the two 
co-contraction indices. However, thorough evaluation of the 
relationship of the individual numeric values to the EMG profiles 
provides insight that the WC metric does not perform well during 
gait. From production of extreme outliers to equivalent numeric 
values in obviously different EMG patterns (Figure  5), we can 
conclusively state that the WC metric is not useful for assessment 
of co-contraction in multi-segmental lower extremity tasks.
Normalization also provided varying results, creating a need 
for careful consideration of normalization procedures before, 
during, and after EMG assessment. Perhaps the most interest-
ing result from the normalization analysis is the congruency of 
the M-max and non-normalized EMG co-contraction indices. 
Choosing not to normalize EMG can be advantageous because 
it avoids data transformation beyond recognition. Our findings 
support arguments presented by Lamontagne regarding EMG 
metrics in stroke (6). While EMG normalization is not strictly 
necessary in this context because calculating a ratio from normal-
ized data effectively normalizes the data twice, most studies in the 
literature employ some type of normalization prior to calculating 
a co-contraction index (46–48). In our sample, maximum value 
normalization suggested a different picture of relative muscle 
activation than either M-max normalization or no normalization.
Co-contraction does not appear to be a universal characteristic 
of impaired gait post-stroke. We do not mean to suggest that exces-
sive co-contraction does not occur in some individuals; however, 
the pattern does not occur sufficiently often enough to be consid-
ered a prominent compensatory strategy following stroke. Ours is 
not the first study to find a lack of strong evidence for the presence 
of excessive co-contraction following stroke. In both the upper 
and lower extremities, the current evidence suggests that reaching 
and walking deficits, respectively, are more likely to result from 
agonist activation impairment than co-contraction (49, 50). It is 
possible that co-contraction represents too narrow of a concept 
to represent and characterize neuromotor pathology post-stroke. 
Accordingly, it may be time to reconsider how we frame the 
problem. Aberrant EMG is descriptively characterized by timing 
and amplitude deficits, and the ability to organize responses to 
the biomechanical constraints of the task and environment (51). 
In this broader context, approaches other than a co-contraction 
metric may better capture the relevant deficits. Some recent 
efforts that have yet to be robustly evaluated in stroke include: 
Ricamato and Hidler’s EMG metric that incorporates both timing 
and amplitude components (52); muscle synergy analysis (53, 
54); and EMG-driven biomechanical modeling that effectively 
accounts for subject-specific neuromuscular constraints on 
dynamic outcomes (55). Our intent is not to prescribe any one of 
these methods to adequately quantify neurophysiologic impair-
ments with EMG. Rather, we would argue that these and other 
alternatives be explored in an effort to learn more about the causal 
mechanisms of gait impairment following stroke.
Beyond an exercise in signal processing and EMG data anal-
ysis, our results provide an opportunity for discussion regard-
ing the neural implications of co-contraction following stroke. 
Heterogeneity among individuals also presents a challenge for 
understanding behavior after stroke, especially in terms of muscle 
activation patterns. Our data illustrate that, even when assessed 
with a variety of metrics, co-contraction does not emerge as 
the strong indicator of neuromotor pathology the literature has 
conditioned us to expect. Instead, we must look to other EMG 
quantification methods that can provide greater insights regard-
ing causal mechanisms of gait impairment.
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